Sunesis Pharmaceuticals (SNSS)

[califax]

Sunesis to Present at Upcoming Investor Conferences

Date : 06/03/2010 @ 7:30AM
Source : MarketWire
Stock : Sunesis Pharmaceuticals, Inc. (SNSS)

http://ih.advfn.com/p.php?pid=nmona&article=43079095&symbol=N^SNSS

SOUTH SAN FRANCISCO, CA -- (Marketwire)
06/03/10
Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS), a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers, today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will present at three upcoming conferences:

9th Annual Needham Healthcare Conference

Wednesday, June 9 at 10:40 a.m. EDT

New York Palace Hotel, New York City


Jefferies 2010 Global Life Sciences Conference

Thursday, June 10 at 8:00 a.m. EDT

Grand Hyatt, New York City


ThinkEquity Mid Year Check-Up on Healthcare

Wednesday, June 16 at 11:30 a.m. EDT

The Princeton Club, New York City

A live webcast of the Jefferies presentation on June 10th will be available on the Sunesis website at http://ir.sunesis.com. A replay of that webcast will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks following the presentation.

About Sunesis Pharmaceuticals

Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, voreloxin, in multiple indications to improve the lives of people with cancer. For additional information on Sunesis, please visit http://www.sunesis.com.

SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc.

Investor and Media Inquiries:

Andrea Rabney

Argot Partners

212-600-1902

Eric Bjerkholt

Sunesis Pharmaceuticals Inc.

650-266-3717